Results 231 to 240 of about 37,267 (288)

Olmesartan‐induced gastritis with no lower gastrointestinal symptoms: A case report

DEN Open, Volume 6, Issue 1, April 2026.
Abstract A 74‐year‐old man with decreased appetite, weight, and heartburn was referred to our hospital. His medications included olmesartan. Esophagogastroduodenoscopy (EGD) revealed antral‐dominant erosive gastritis and nodular mucosa. A gastric biopsy revealed inflammatory cell infiltration.
Satoshi Kosaka, Miki Kamiyama, Masahiro Ochi   +2 more
wiley   +1 more source

Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment. [PDF]

Blood Adv
Sanchorawala V, Barroso B, Shelton A, Goetz E, Mendelson L, Joshi T, Burke N, Sloan JM, Staron A.   +8 more
europepmc   +1 more source

Skin Biopsy as a Diagnostic Tool for ATTRv Amyloid Neuropathy in the UK

Journal of the Peripheral Nervous System, Volume 30, Issue 3, September 2025.
ABSTRACT Objective Gene silencing therapy for ATTRv has revolutionised treatment. In minimally symptomatic, early neuropathic disease, skin biopsy can aid in the diagnosis of ATTRv‐PN, assessing both amyloid deposition and IENFD. Our aim was to study the value of performing skin biopsies in the diagnosis of ATTRv‐PN in UK patients and to assess the ...
Luke F. O'Donnell, Victor Zhang, Roy Carganillo, Alexander M. Rossor, Matilde Laura, Mariola Skorupinska, Janet A. Gilbertson, Dorota Rowczenio, Yousuf Razvi, Julian D. Gillmore, Mary M. Reilly   +10 more
wiley   +1 more source

Early dFLC response by C1D7 predicts complete hematologic response in systemic AL amyloidosis. [PDF]

Ann Hematol
Liu Y, Bi J, Dou X, Peng N, Wen L, Zhao Y, Huang X, Lu J.   +7 more
europepmc   +1 more source

A Rare Case with Recurrent Abdominal Pain as the First Symptom: AL Amyloidosis with Colon Involvement Combined with Pulmonary Adenocarcinoma. [PDF]

J Inflamm Res
Wei J, Hu Y, Lu C, Hu M, Wang Q.
europepmc   +1 more source

Subtle Alterations in Hippocampal Neuronal Activity Coincide With Early Sex‐Specific Differences in Amyloidosis and Microglia in a Pre‐Symptomatic Mouse Model of Alzheimer‐Like Pathology

Glia, Volume 73, Issue 8, Page 1727-1745, August 2025.
Main Points In a pre‐symptomatic mouse model of Alzheimer disease, despite higher amyloid‐β load females display less plaques than males. More efficient synaptic transmission as well as less microgliosis point to better early coping with pathogenesis in females.
Thomas Chaigneau, Sha Sha, Candice M. Roux, Saba Aïd, Alice Faucher, Yannick Chantran, Guillaume Dorothée, Slavica Krantic   +7 more
wiley   +1 more source

Light-Chain (AL) Amyloidosis as a Rare Cause of Upper Gastrointestinal Bleeding: A Case Report and Systematic Literature Review. [PDF]

Case Rep Oncol
Müller C, Warth A.
europepmc   +1 more source

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

, 2013
Ashutosh Wechalekar, Stefan Schönland, Efstathios Kastritis, Julian D. Gillmore, Meletios Α. Dimopoulos, Thirusha Lane, Andrea Foli, Darren Foard, Paolo Milani, Lisa Rannigan, Ute Hegenbart, Philip N. Hawkins, Giampaolo Merlini, Giovanni Palladini   +13 more
openalex   +1 more source

Prevalence of cardiac fibrosis and infiltrative cardiomyopathy in patients with advanced conduction system disease

Journal of Arrhythmia, Volume 41, Issue 4, August 2025.
Prevalence of cardiac fibrosis and sarcoidosis in patients with advanced conduction system disease. Abstract Background Conduction system disease may represent an early manifestation of underlying structural heart disease, including infiltrative disorders.
Jeremy William, Haider Muthana, Joseph Hogarty, Andrew Taylor, James L. Hare, Justin Mariani, Hitesh Patel, Geoff Wong, Dion Stub, David M. Kaye, Sandeep Prabhu, Peter M. Kistler, Aleksandr Voskoboinik   +12 more
wiley   +1 more source

Treatment of AL amyloidosis in the era of novel immune and cellular therapies. [PDF]

Front Oncol
Sarubbi C, Abowali H, Varga C, Landau H.
europepmc   +1 more source